Department of Nephrology, First Medical Center of Chinese PLA General Hospital, National Key Laboratory of Kidney Diseases, National Clinical Research Center for Kidney Diseases, Beijing Key Laboratory of Kidney Diseases Research, Beijing, 100853, China.
Department of Urology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
BMC Nephrol. 2024 Apr 1;25(1):118. doi: 10.1186/s12882-024-03556-4.
Nonmalignant pleural effusion (NMPE) is common and remains a definite health care problem. Pleural effusion was supposed to be a risk factor for acute kidney injury (AKI). Incidence of AKI in NMPE patients and whether there is correlation between the size of effusions and AKI is unknown.
To assess the incidence of AKI in NMPE inpatients and its association with effusion size.
We conducted a retrospective cohort study of inpatients admitted to the Chinese PLA General Hospital with pleural effusion from 2018-2021. All patients with pleural effusions confirmed by chest radiography (CT or X-ray) were included, excluding patients with diagnosis of malignancy, chronic dialysis, end-stage renal disease (ESRD), community-acquired AKI, hospital-acquired AKI before chest radiography, and fewer than two serum creatinine tests during hospitalization. Multivariate logistic regression and LASSO logistic regression models were used to identify risk factors associated with AKI. Subgroup analyses and interaction tests for effusion volume were performed adjusted for the variables selected by LASSO. Causal mediation analysis was used to estimate the mediating effect of heart failure, pneumonia, and eGFR < 60 ml/min/1.73m on AKI through effusion volume.
NMPE was present in 7.8% of internal medicine inpatients. Of the 3047 patients included, 360 (11.8%) developed AKI during hospitalization. After adjustment by covariates selected by LASSO, moderate and large effusions increased the risk of AKI compared with small effusions (moderate: OR 1.47, 95%CI 1.11-1.94 p = 0.006; large: OR 1.86, 95%CI 1.05-3.20 p = 0.028). No significant modification effect was observed among age, gender, diabetes, bilateral effusions, and eGFR. Volume of effusions mediated 6.8% (p = 0.005), 4.0% (p = 0.046) and 4.6% (p < 0.001) of the effect of heart failure, pneumonia and low eGFR on the development of AKI respectively.
The incidence of AKI is high among NMPE patients. Moderate and large effusion volume is independently associated with AKI compared to small size. The effusion size acts as a mediator in heart failure, pneumonia, and eGFR.
非恶性胸腔积液(NMPE)很常见,仍是一个明确的医疗保健问题。胸腔积液被认为是急性肾损伤(AKI)的一个危险因素。NMPE 患者 AKI 的发生率以及胸腔积液量与 AKI 之间是否存在相关性尚不清楚。
评估 NMPE 住院患者 AKI 的发生率及其与胸腔积液量的关系。
我们对 2018-2021 年在中国人民解放军总医院因胸腔积液住院的患者进行了回顾性队列研究。所有经胸部 X 线(CT 或 X 线)证实有胸腔积液的患者均被纳入研究,排除恶性肿瘤、慢性透析、终末期肾病(ESRD)、社区获得性 AKI、胸部 X 线检查前获得的医院获得性 AKI 以及住院期间少于两次血清肌酐检查的患者。采用多变量逻辑回归和 LASSO 逻辑回归模型来识别与 AKI 相关的危险因素。对 LASSO 选择的变量进行调整后,进行亚组分析和胸腔积液量的交互检验。采用因果中介分析来估计心力衰竭、肺炎和 eGFR<60ml/min/1.73m 通过胸腔积液量对 AKI 的中介作用。
内科住院患者中 NMPE 占 7.8%。在纳入的 3047 名患者中,360 名(11.8%)在住院期间发生 AKI。在经过 LASSO 选择的协变量调整后,中量和大量胸腔积液与小量胸腔积液相比,增加 AKI 的风险(中量:OR 1.47,95%CI 1.11-1.94,p=0.006;大量:OR 1.86,95%CI 1.05-3.20,p=0.028)。年龄、性别、糖尿病、双侧胸腔积液和 eGFR 之间未见显著的修饰作用。胸腔积液量分别介导心力衰竭、肺炎和低 eGFR 对 AKI 发生的 6.8%(p=0.005)、4.0%(p=0.046)和 4.6%(p<0.001)的作用。
NMPE 患者 AKI 的发生率较高。与小量胸腔积液相比,中量和大量胸腔积液与 AKI 独立相关。胸腔积液量是心力衰竭、肺炎和 eGFR 的中介因素。